Day One Biopharmaceutical Stock (NASDAQ: DAWN) stock price, news, charts, stock research, profile.
Open | $14.32 |
Close | $14.78 |
Volume / Avg. | 2.25M / 977.95K |
Day Range | $14.13 - $14.91 |
52 Wk Range | 9.67 - 18.07 |
Market Cap | $1.46B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 59 |
Short Interest | 17.39% |
Days to Cover | 18.4 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Day One Biopharmaceutical (NASDAQ:DAWN) through any online brokerage.
Other companies in Day One Biopharmaceutical’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT), Syndax Pharmaceuticals (NASDAQ:SNDX) and Arcutis Biotherapeutics (NASDAQ:ARQT).
Day One Biopharmaceutical has a consensus price target of $36.38.
The stock price for Day One Biopharmaceutical (NASDAQ: DAWN) is $14.8 last updated September 20, 2024 at 7:02 PM EDT.
There are no upcoming dividends for Day One Biopharmaceutical.
Day One Biopharmaceutical’s Q3 earnings are confirmed for Monday, November 4, 2024.
There is no upcoming split for Day One Biopharmaceutical.
Day One Biopharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.